Triple
T23431865
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Regulation (EC) No 1901/2006 |
E563353
|
entity |
| Predicate | amends |
P1121
|
FINISHED |
| Object | Directive 2001/83/EC |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Directive 2001/83/EC | Statement: [Regulation (EC) No 1901/2006, amends, Directive 2001/83/EC]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Directive 2001/83/EC Context triple: [Regulation (EC) No 1901/2006, amends, Directive 2001/83/EC]
-
A.
Directive 2001/83/EC
chosen
Directive 2001/83/EC is a key European Union law that sets the framework for the authorization, manufacture, distribution, and pharmacovigilance of medicinal products for human use across EU member states.
-
B.
Directive 2001/82/EC
Directive 2001/82/EC is a key European Union law that sets out the rules for the authorization, supervision, and pharmacovigilance of veterinary medicinal products across EU member states.
-
C.
Directive 2006/86/EC
Directive 2006/86/EC is a European Union legal act that sets detailed technical requirements for the traceability, notification of serious adverse reactions and events, and quality and safety standards for human tissues and cells used in medical treatments.
-
D.
Directive 2001/20/EC
Directive 2001/20/EC was an EU legislative act that established the original regulatory framework for the conduct of clinical trials on medicinal products for human use within the European Union.
-
E.
Directive 2010/84/EU
Directive 2010/84/EU is a European Union legislative act that significantly strengthened and modernized the EU pharmacovigilance system to improve the monitoring and safety of medicinal products for human use.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e24553980c8190bb66a2ae0bdab125 |
completed | April 17, 2026, 2:36 p.m. |
| NER | Named-entity recognition | batch_69f1a5d920548190904f80c7c40cba06 |
completed | April 29, 2026, 6:31 a.m. |
Created at: April 17, 2026, 5:49 p.m.